R61/33 - VR Study Phase 4

Recruiting Phase 4 Interventional Study
Attention Deficit Hyperactivity Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 25
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
252 (estimated)
Sponsor
Rutgers, The State University of New Jersey · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedb…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants must meet DSM-5 criteria for ADHD * Between the ages of 18 and 25 * Given high rates of comorbidities in college students with ADHD, participants who meet criteria for ODD, anxiety or depressive disorders on the diagnostic interview are not excluded * Participants…
Contacts

Joshua M Langberg, PhD

(848) 445-2000

jl3079@gsapp.rutgers.edu

CONTACT

Sophia R Frontale, MPS

3155062647

sf924@gsapp.rutgers.edu

CONTACT